Abstract
The evidence that there is clinical heterogeneity of type 1 diabetes is reviewed and the implications for genetic studies are discussed. In the past year, genome-wide linkage analysis of 1435 multiplex families was reported. Additionally, confirmed evidence for association of specific markers at two loci (PTPN22, OAS1) as well as failure to replicate three others (IL12B, SUMO4, PAX4) is discussed. Some common themes are identified and suggestions for improvements are made. We look forward to the results from genome-wide association studies.
Similar content being viewed by others
References and Recommended Reading
Onengut-Gumuscu S, Concannon P: The genetics of type 1 diabetes: lessons learned and future challenges. J Autoimmun 2005, 25(suppl):34–39.
Smink LJ, Helton EM, Healy BC, et al.: T1Dbase, a community web-based resource for type 1 diabetes research. Nucleic Acids Res 2005, 33(Database issue):D544-D549.
American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28(suppl 1): S37-S42.
Karjalainen J, Salmela P, Ilonen J, et al.: A comparison of childhood and adult type I diabetes mellitus. N Engl J Med 1989, 320:881–886.
Gillespie KM, Gale EA, Bingley PJ: High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes 2002, 51:210–214.
Gianani R, Eisenbarth GS: The stages of type 1A diabetes: 2005. Immunol Rev 2005, 204:232–249.
Palmer JP, Fleming GA, Greenbaum CJ, et al.: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 2004, 53:250–264.
Foulis AK, Liddle CN, Farquharson MA, et al.: The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986, 29:267–274.
Hall JM, Lee MK, Newman B, et al.: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990, 250:1684–1689.
Schellenberg GD, Bird TD, Wijsman EM, et al.: Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992, 258:668–671.
King RA, Rotter JI, Motulsky AG, eds: The Genetic Basis of Common Diseases, edn 2. New York, NY: Oxford University Press; 2002.
Pociot F, Norgaard K, Hobolth N, et al.: A nationwide population-based study of the familial aggregation of type 1 (insulin-dependent) diabetes mellitus in Denmark. Danish Study Group of Diabetes in Childhood. Diabetologia 1993, 36:870–875.
Kyvik KO, Green A, Beck-Nielsen H: Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ 1995, 311:913–917.
Fava D, Gardner S, Pyke D, Leslie RD: Evidence that the age at diagnosis of IDDM is genetically determined. Diabetes Care 1998, 21:925–929.
Hyttinen V, Kaprio J, Kinnunen L, et al.: Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 2003, 52:1052–1055.
Familial risk of type I diabetes in European children. The Eurodiab Ace Study Group and The Eurodiab Ace Substudy 2 Study Group. Diabetologia 1998, 41:1151–1156. [published erratum appears in Diabetologia 1999, 42:262.]
Harjutsalo V, Podar T, Tuomilehto J: Cumulative incidence of type 1 diabetes in 10,168 siblings of Finnish youngonset type 1 diabetic patients. Diabetes 2005, 54:563–569. They performed a large-scale genetic-epidemiologic study focusing on features that are associated with differences in risk of T1D in siblings.
Rami B, Waldhor T, Schober E: Incidence of type I diabetes mellitus in children and young adults in the province of Upper Austria, 1994–1996. Diabetologia 2001, 44(suppl 3): B45-B47.
Guo SW, Tuomilehto J: Preferential transmission of type 1 diabetes from parents to offspring: fact or artifact? Genet Epidemiol 2002, 23:323–334.
Larsen CE, Alper CA: The genetics of HLA-associated disease. Curr Opin Immunol 2004, 16:660–667.
Concannon P, Erlich HA, Julier C, et al.: Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 2005, 54:2995–3001. They performed a genome-wide linkage analysis of new families and combined the data with families from previous studies.
Lernmark A, Ott J: Sometimes it's hot, sometimes it's not. Nat Genet 1998, 19:213–214.
Vieland VJ, Logue M: HLODs, trait models, and ascertainment: implications of admixture for parameter estimation and linkage detection. Hum Hered 2002, 53:23–35.
Edwards JH: Sib-pairs in multifactorial disorders: the sib-similarity problem. Clin Genet 2003, 63:1–9.
Zollner S, Wen X, Hanchard NA, et al.: Evidence for extensive transmission distortion in the human genome. Am J Hum Genet 2004, 74:62–72.
Morahan G, Huang D, Ymer SI, et al.: Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet 2001, 27:218–221.[Published erratum appears in Nat Genet 2001, 27:346.]
Nistico L, Giorgi G, Giordano M, et al.: IL12B polymorphism and type 1 diabetes in the Italian population: a case-control study. Diabetes 2002, 51:1649–1550.
McCormack RM, Maxwell AP, Carson DJ, et al.: The IL12B 3’ untranslated region DNA polymorphism is not associated with early-onset type 1 diabetes. Genes Immun 2002, 3:433–435.
Bergholdt R, Ghandil P, Johannesen J, et al.: Genetic and functional evaluation of an interleukin-12 polymorphism (IDDM18) in families with type 1 diabetes. J Med Genet 2004, 41:e39.
Johansson S, Lie BA, Thorsby E, Undlien DE: The polymorphism in the 3’ untranslated region of IL12B has a negligible effect on the susceptibility to develop type 1 diabetes in Norway. Immunogenetics 2001, 53:603–605.
Davoodi-Semiromi A, Yang JJ, She JX: IL-12p40 is associated with type 1 diabetes in Caucasian-American families. Diabetes 2002, 51:2334–2336.
Santiago JL, Martinez A, de La Calle H, et al.: Th1 cytokine polymorphisms in Spanish patients with type 1 diabetes. Hum Immunol 2005, 66:897–902.
Dahlman I, Eaves IA, Kosoy R, et al.: Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002, 30:149–150.
Windsor L, Morahan G, Huang D, et al.: Alleles of the IL12B 3’UTR associate with late onset of type 1 diabetes. Hum Immunol 2004, 65:1432–1436.
Bottini N, Musumeci L, Alonso A, et al.: A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004, 36:337–338. The first description that a missense variant in PTPN22 is associated with T1D.
Vang T, Congia M, Macis MD, et al.: Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005, 37:1317–1319.
Smyth D, Cooper JD, Collins JE, et al.: Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004, 53:3020–3023.
Onengut-Gumuscu S, Ewens KG, Spielman RS, Concannon P: A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families. Genes Immun 2004, 5:678–680.
Ladner MB, Bottini N, Valdes AM, Noble JA: Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum Immunol 2005, 66:60–64.
Zheng W, She JX: Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes. Diabetes 2005, 54:906–908.
Qu H, Tessier MC, Hudson TJ, Polychronakos C: Confirmation of the association of the R620W polymorphism in the protein tyrosine phosphatase PTPN22 with type 1 diabetes in a family based study. J Med Genet 2005, 42:266–270.
Begovich AB, Carlton VE, Honigberg LA, et al.: A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004, 75:330–337.
Kyogoku C, Langefeld CD, Ortmann WA, et al.: Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004, 75:504–507.
Carlton VE, Hu X, Chokkalingam AP, et al.: PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 2005, 77:567–581.
Bonnevie-Nielsen V, Field LL, Lu S, et al.: Variation in antiviral 2’,5’-oligoadenylate synthetase (2’5’AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am J Hum Genet 2005, 76:623–633.
Field LL, Bonnevie-Nielsen V, Pociot F, et al.: OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. Diabetes 2005, 54:1588–1591.
Tessier MC, Qu HQ, Frechette R, et al.: Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype? J Med Genet 2006, 43:129–132.
Guo D, Li M, Zhang Y, et al.: A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 2004, 36:837–841.
Bohren KM, Nadkarni V, Song JH, et al.: A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem 2004, 279:27233–27238.
Lernmark A, Eisenbarth G, Ducat L, et al.: Family cell lines available for research—an endangered resource? Am J Hum Genet 1997, 61:778–779.
Smyth DJ, Howson JM, Lowe CE, et al.: Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet 2005, 37:110–111; author reply 112–113.
Qu H, Bharaj B, Liu XQ, et al.: Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet 2005, 37:111–112; author reply 112–113.
Park Y, Park S, Kang J, et al.: Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet 2005, 37:112; author reply 112–113.
Wang CY, Yang P, She JX: Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes: author reply. Nat Genet 2005, 37:112–113.
Kosoy R, Concannon P: Functional variants in SUMO4, TAB2, and NFkappaB and the risk of type 1 diabetes. Genes Immun 2005, 6:231–235.
Biason-Lauber A, Boehm B, Lang-Muritano M, et al.: Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 2005, 48:900–905.
Gylvin T, Bergholdt R, Nerup J, Pociot F: To: Biason-Lauber A, Boehm B, Lang-Muritano M et al. (2005) association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900–905. Diabetologia 2005, 48:2183–2184.
Hermann R, Mantere J, Lipponen K, et al.: Lack of association of PAX4 gene with type 1 diabetes in the Finnish and Hungarian populations. Diabetes 2005, 54:2816–2819.
Maier LM, Cooper JD, Walker N, et al.: Comment to: Biason-Lauber A, Boehm B, Lang-Muritano M et al. (2005) association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900–905. Diabetologia 2005, 48:2180–2182.
Paterson AD:To: Biason-Lauber A, Boehm B, Lang-Muritano M et al. (2005) association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900–905. Diabetologia 2005, 48:2179.
Wittke-Thompson JK, Pluzhnikov A, Cox NJ: Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 2005, 76:967–986.
Biason-Lauber A, Boehm B, Lang-Muritano M, et al.: Reply to comment on: Biason-Lauber A, Boehm B, Lang-Muritano M et al. (2005) association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 48:900–905. Diabetologia 2005, 48:2185–2186.
Vella A, Cooper JD, Lowe CE, et al.: Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 2005, 76:773–779.
Maier LM, Smyth DJ, Vella A, et al.: Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes. BMC Genet 2005, 6:9.
Campbell CD, Ogburn EL, Lunetta KL, et al.: Demonstrating stratification in a European American population. Nat Genet 2005, 37:868–872.
Hinds DA, Stuve LL, Nilsen GB, et al.: Whole-genome patterns of common DNA variation in three human populations. Science 2005, 307:1072–1079.
Gibbs RA, Belmont JW, Hardenbol P, et al.: The International HapMap Project. Nature 2003, 426:789–796.
Altshuler D, Brooks LD, Chakravarti A, et al.: A haplotype map of the human genome. Nature 2005, 437:1299–1320.
Fredman D, White SJ, Potter S, et al.: Complex SNP-related sequence variation in segmental genome duplications. Nat Genet 2004, 36:861–866.
Weber JL, David D, Heil J, et al.: Human diallelic insertion/ deletion polymorphisms. Am J Hum Genet 2002, 71:854–862.
Bhangale TR, Rieder MJ, Livingston RJ, Nickerson DA: Comprehensive identification and characterization of diallelic insertion-deletion polymorphisms in 330 human candidate genes. Hum Mol Genet 2005, 14:59–69.
Stefansson H, Helgason A, Thorleifsson G, et al.: A common inversion under selection in Europeans. Nat Genet 2005, 37:129–137.
Iafrate AJ, Feuk L, Rivera MN, et al.: Detection of largescale variation in the human genome. Nat Genet 2004, 36:949–951.
Tuzun E, Sharp AJ, Bailey JA, et al.: Fine-scale structural variation of the human genome. Nat Genet 2005, 37:727–732.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Paterson, A.D. Genetic epidemiology of type 1 diabetes. Curr Diab Rep 6, 139–146 (2006). https://doi.org/10.1007/s11892-006-0025-8
Issue Date:
DOI: https://doi.org/10.1007/s11892-006-0025-8